MT Newswires100d agoneutral
AbbVie Trims Full-Year Profit Outlook Due to Apogee AcquisitionNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Yahoo Finance Video101d agoneutralVIDEO
Friday's market movers: Oil earnings and consumer sentiment dataYahoo Finance Video101d agoneutralVIDEO
Friday’s market movers: Oil earnings and consumer sentiment data24/7 Wall St.104d agoneutral
Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a PaycheckMotley Fool112d agoneutral
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?StockStory128d agoneutral
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics StocksThe Wall Street Journal130d agoneutral
Galderma Shares Fall After Bid to Launch Botox Rival in U.S. Hits FDA SetbackThe Wall Street Journal131d agoneutral
Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial